Prilosec Summary Judgment Narrows Scope Of Patent Infringement Case

AstraZeneca's delayed-release formulation patents for its gastric ulcer drug Prilosec will be the focus of patent infringement litigation after a federal court dismissed as invalid one of the company's "method of treatment" patents.